Status:
COMPLETED
Posterior Capsule Opacification Study
Lead Sponsor:
Aurolab
Conditions:
Cataract
Eligibility:
All Genders
40-65 years
Phase:
PHASE4
Brief Summary
First object is to compare square edge PMMA with round edge PMMA IOL where the materials are same. Next objective is to compare square edge PMMA IOL with Acrysof IOL where the materials are different
Detailed Description
Cataract is the vision impairing disease characterized by gradual, progressive thickening of the lens. Posterior Capsular Opacification (PCO) remains the most frequent long term complication. This is ...
Eligibility Criteria
Inclusion
- Age 40 to 65 years
- Bilateral senile cataract
- Pupil should be at least 7mm dilated
- Nuclear sclerosis grade I, II and III
- Patient willing for second eye surgery within 3 months
Exclusion
- Debilitated old patients
- Cardiac and serious illness
- Intraoperative complications including PC rent, Zonular dialysis and Rhexis tear
- Inherent zonular weakness
- Glaucoma patients
- Relative afferent papillary defect (RAPD)
- Shallow anterior chamber
- Pseudoexfoliation
- Traumatic cataract
- Uveitis and complicated cataract
- One eyed patients
- Corneal pathology
- Post segment pathology including diabetic retinopathy
- Dense Posterior subcapsular cataract (PSCC) and Posterior polar cataract (PPC)
- High myopic and hyperopic patient
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00312299
Start Date
April 1 2006
End Date
January 1 2012
Last Update
July 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aravind Eye Hospital
Madurai, Tamil Nadu, India, 625020